Dividends Calendar Earnings Calendar
OVID

OVID | Ovid Therapeutics Inc

2.96 -0.74 (-20.08%) 
Healthcare sector
Ovid Therapeutics Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   United States of America
  • Number of employees::   67
Investor Relations : investors.ovidrx.com

Company profile

Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The company?s most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing soticlestat in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

    Address

    1460 Broadway
    Suite 15021
    New York, NY 10036
    United States



      Jump to (Finance sites)

      Google     
               

      Research 


      Investor page

      investors.ovidrx.com

      If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


      Consensus
      BUY 50
      HOLD 50
      SELL 0

      Their Official Profiles 

      TwitterLinkedInInstagramYoutube

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      The Intelligent Investor
      Buy on Amazon

      Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

      The best book on investing ever written.
      -- Warren Buffet